[Anti-chromatin antibodies in juvenile rheumatoid arthritis].

OBJECTIVE to evaluate the prevalence and clinical significance of anti-chromatin antibodies (Abs) in juvenile rheumatoid arthritis (JRA). METHODS IgG anti-chromatin Abs were detected by an enzyme-linked immunosorbent assay (ELISA), in sera of 94 children with JRA (10 children with systemic, 38 with polyarticular and 46 with oligoarticular disease onset). As control group, 33 age- and-sex-matched healthy children (HC) were also examined. RESULTS Abs to chromatin were detected in 24/94 (25.5%) of children suffering from JRA. Particularly, the higher prevalence of anti-chromatin Abs has been found in children with oligoarticular (30,4%) and polyarticular (23.7%) onset JRA. In these groups Abs titers were significantly higher compared to systemic JRA and HC (p=0.003). Anti-chromatin Abs were observed more frequently in patients with oligoarticular disease and chronic uveitis (21.7%). Furthermore, higher levels of anti-chromatin Abs has been found in all the patients treated with anti-TNF-alpha therapy (p< 0.0001). CONCLUSIONS our results confirm previous data about the prevalence of anti-chromatin Abs in JRA. These Abs were significantly higher in the group of patients with oligoarticular onset with past or present history of ocular involvement and in the group with polyarticular JRA treated with biologic therapy. A long-term follow-up study could be useful to evaluate the potential utility of these autoantibodies.

[1]  F. Ingegnoli,et al.  Autoantibodies to chromatin: prevalence and clinical significance in juvenile rheumatoid arthritis. , 2004, Clinical and experimental rheumatology.

[2]  E. Veys,et al.  Antinuclear antibodies following infliximab treatment in patients with rheumatoid arthritis or spondylarthropathy. , 2003, Arthritis and rheumatism.

[3]  J. Kanski,et al.  An evaluation of baseline risk factors predicting severity in juvenile idiopathic arthritis associated uveitis and other chronic anterior uveitis in early childhood , 2002, The British journal of ophthalmology.

[4]  A. T. Berk,et al.  Uveitis in juvenile arthritis , 2001, Ocular immunology and inflammation.

[5]  Y. Saeki,et al.  TUMOUR NECROSIS FACTOR α (TNF-α) INTERFERES WITH Fas-MEDIATED APOPTOTIC CELL DEATH ON RHEUMATOID ARTHRITIS (RA) SYNOVIAL CELLS: A POSSIBLE MECHANISM OF RHEUMATOID SYNOVIAL HYPERPLASIA AND A CLINICAL BENEFIT OF ANTI-TNF-α THERAPY FOR RA , 2000 .

[6]  J. Piette,et al.  The key role of nucleosomes in lupus. , 1999, Arthritis and rheumatism.

[7]  O. Førre,et al.  Analysis of the NF-kappa B p65 subunit, Fas antigen, Fas ligand and Bcl-2-related proteins in the synovium of RA and polyarticular JRA. , 1998, Clinical and experimental rheumatology.

[8]  T. Richmond,et al.  Crystal structure of the nucleosome core particle at 2.8 Å resolution , 1997, Nature.

[9]  A. Rosenberg,et al.  Studies on associations of antinuclear antibodies with antibodies to an uveitogenic peptide of retinal S antigen in children with uveitis. , 1996, The Journal of rheumatology.

[10]  J. Piette,et al.  Presence of nucleosome-restricted antibodies in patients with systemic lupus erythematosus. , 1995, Arthritis and rheumatism.

[11]  C. Kramers,et al.  Apoptosis, nucleosomes, and nephritis in systemic lupus erythematosus. , 1995, Kidney international.

[12]  E. Tan,et al.  Autoantibodies in the diagnosis of systemicrheumatic diseases , 1995 .

[13]  A. Rosen,et al.  Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes , 1994, The Journal of experimental medicine.

[14]  R. Burlingame,et al.  Autoantibodies to chromatin components in juvenile rheumatoid arthritis. , 1993, Arthritis and rheumatism.

[15]  P. Woo,et al.  Study of antibodies to histones and histone synthetic peptides in pauciarticular juvenile chronic arthritis. , 1993, British journal of rheumatology.

[16]  T. Southwood,et al.  Ophthalmological screening in juvenile arthritis: should the frequency of screening be based on the risk of developing chronic iridocyclitis? , 1992, British journal of rheumatology.

[17]  L. Bohm,et al.  Antihistone antibodies in antinuclear antibody-positive juvenile arthritis. , 1990, Arthritis and rheumatism.

[18]  A. Mirzabekov,et al.  Structure of nucleosomes and organization of internucleosomal DNA in chromatin. , 1990, Journal of molecular biology.

[19]  J. Webb,et al.  Antihistone antibodies in rheumatoid arthritis and Felty's syndrome. , 1989, Arthritis and rheumatism.

[20]  E. Silverman,et al.  ANTIBODIES TO HISTONES H1 AND H5 IN SERA OF PATIENTS WITH JUVENILE RHEUMATOID ARTHRITIS , 1989, Arthritis and rheumatism.

[21]  L. Donoso,et al.  Sequence homology between yeast histone H3 and uveitopathogenic site of S-antigen: lymphocyte cross-reaction and adoptive transfer of the disease. , 1989, Cellular immunology.

[22]  O. Rekvig,et al.  Identification of antihistone antibodies in subsets of juvenile chronic arthritis. , 1989, Annals of the rheumatic diseases.

[23]  A. Rosenberg.  The clinical associations of antinuclear antibodies in juvenile rheumatoid arthritis. , 1988, Clinical immunology and immunopathology.

[24]  A. Rosenberg,et al.  The relationship between ocular and articular disease activity in children with juvenile rheumatoid arthritis and associated uveitis. , 1986, Arthritis and rheumatism.

[25]  J. Baum,et al.  Current proposed revision of JRA Criteria. JRA Criteria Subcommittee of the Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Section of The Arthritis Foundation. , 1977, Arthritis and rheumatism.

[26]  E. Holborow,et al.  The association of antinuclear antibodies with the chronic iridocyclitis of juvenile rheumatoid arthritis (Still's disease). , 1974, Arthritis and rheumatism.

[27]  Y. Saeki,et al.  Tumour necrosis factor alpha (TNF-alpha) interferes with Fas-mediated apoptotic cell death on rheumatoid arthritis (RA) synovial cells: a possible mechanism of rheumatoid synovial hyperplasia and a clinical benefit of anti-TNF-alpha therapy for RA. , 2000, Cytokine.

[28]  E. Tan,et al.  Autoantibodies in the diagnosis of systemic rheumatic diseases. , 1995, Seminars in arthritis and rheumatism.